annual CFF:
$12.77M+$2.41M(+23.30%)Summary
- As of today (August 29, 2025), ABCL annual cash flow from financing activities is $12.77 million, with the most recent change of +$2.41 million (+23.30%) on December 31, 2024.
- During the last 3 years, ABCL annual CFF has risen by +$16.66 million (+428.59%).
- ABCL annual CFF is now -98.13% below its all-time high of $683.65 million, reached on December 31, 2020.
Performance
ABCL Cash from financing Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
quarterly CFF:
-$3.33M-$9.30M(-155.74%)Summary
- As of today (August 29, 2025), ABCL quarterly cash flow from financing activities is -$3.33 million, with the most recent change of -$9.30 million (-155.74%) on June 1, 2025.
- Over the past year, ABCL quarterly CFF has dropped by -$5.94 million (-227.39%).
- ABCL quarterly CFF is now -100.53% below its all-time high of $629.01 million, reached on December 31, 2020.
Performance
ABCL quarterly CFF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
TTM CFF:
$9.71M-$5.94M(-37.96%)Summary
- As of today (August 29, 2025), ABCL TTM cash flow from financing activities is $9.71 million, with the most recent change of -$5.94 million (-37.96%) on June 1, 2025.
- Over the past year, ABCL TTM CFF has dropped by -$6.04 million (-38.34%).
- ABCL TTM CFF is now -98.62% below its all-time high of $705.00 million, reached on December 31, 2020.
Performance
ABCL TTM CFF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Cash from financing Formula
CFF = Cash Inflows from Financing Activities − Cash Outflows from Financing Activities
ABCL Cash from financing Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +23.3% | -227.4% | -38.3% |
| 3 y3 years | +428.6% | -381.8% | +971.6% |
| 5 y5 years | +6448.2% | -1061.7% | -89.0% |
ABCL Cash from financing Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | at high | +428.6% | -150.0% | at low | -38.3% | +721.9% |
| 5 y | 5-year | -98.1% | +428.6% | -100.5% | +72.5% | -98.6% | +278.0% |
| alltime | all time | -98.1% | +428.6% | -100.5% | +72.5% | -98.6% | +278.0% |
ABCL Cash from financing History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Jun 2025 | - | -$3.33M(-155.7%) | $9.71M(-38.0%) |
| Mar 2025 | - | $5.97M(+52.5%) | $15.65M(+25.1%) |
| Dec 2024 | $12.77M(+23.3%) | $3.92M(+24.3%) | $12.51M(+2.2%) |
| Sep 2024 | - | $3.15M(+20.6%) | $12.24M(-22.3%) |
| Jun 2024 | - | $2.61M(-7.7%) | $15.74M(+16.2%) |
| Mar 2024 | - | $2.83M(-22.3%) | $13.55M(+32.0%) |
| Dec 2023 | $10.36M(-736.1%) | $3.64M(-45.3%) | $10.26M(+46.6%) |
| Sep 2023 | - | $6.66M(+1489.4%) | $7.00M(+1900.5%) |
| Jun 2023 | - | $418.90K(-191.5%) | $349.90K(-68.5%) |
| Mar 2023 | - | -$458.00K(-220.2%) | $1.11M(-171.2%) |
| Dec 2022 | -$1.63M | $380.90K(+4602.5%) | -$1.56M(+1290.1%) |
| Sep 2022 | - | $8100.00(-99.3%) | -$112.30K(-112.4%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Jun 2022 | - | $1.18M(-137.7%) | $905.90K(-116.6%) |
| Mar 2022 | - | -$3.13M(-271.1%) | -$5.45M(+41.1%) |
| Dec 2021 | -$3.89M(-100.6%) | $1.83M(+78.3%) | -$3.86M(-100.6%) |
| Sep 2021 | - | $1.03M(-119.8%) | $623.31M(+2.1%) |
| Jun 2021 | - | -$5.18M(+235.6%) | $610.19M(-0.9%) |
| Mar 2021 | - | -$1.54M(-100.2%) | $615.72M(-12.7%) |
| Dec 2020 | $683.65M(>+9900.0%) | $629.01M(-5301.7%) | $705.00M(+827.7%) |
| Sep 2020 | - | -$12.09M(-3594.9%) | $75.99M(-13.7%) |
| Jun 2020 | - | $346.00K(-99.6%) | $88.08M(+0.4%) |
| Mar 2020 | - | $87.74M | $87.74M |
| Dec 2019 | $195.00K(-98.4%) | - | - |
| Dec 2018 | $12.19M | - | - |
FAQ
- What is AbCellera Biologics Inc. annual cash flow from financing activities?
- What is the all time high annual CFF for AbCellera Biologics Inc.?
- What is AbCellera Biologics Inc. annual CFF year-on-year change?
- What is AbCellera Biologics Inc. quarterly cash flow from financing activities?
- What is the all time high quarterly CFF for AbCellera Biologics Inc.?
- What is AbCellera Biologics Inc. quarterly CFF year-on-year change?
- What is AbCellera Biologics Inc. TTM cash flow from financing activities?
- What is the all time high TTM CFF for AbCellera Biologics Inc.?
- What is AbCellera Biologics Inc. TTM CFF year-on-year change?
What is AbCellera Biologics Inc. annual cash flow from financing activities?
The current annual CFF of ABCL is $12.77M
What is the all time high annual CFF for AbCellera Biologics Inc.?
AbCellera Biologics Inc. all-time high annual cash flow from financing activities is $683.65M
What is AbCellera Biologics Inc. annual CFF year-on-year change?
Over the past year, ABCL annual cash flow from financing activities has changed by +$2.41M (+23.30%)
What is AbCellera Biologics Inc. quarterly cash flow from financing activities?
The current quarterly CFF of ABCL is -$3.33M
What is the all time high quarterly CFF for AbCellera Biologics Inc.?
AbCellera Biologics Inc. all-time high quarterly cash flow from financing activities is $629.01M
What is AbCellera Biologics Inc. quarterly CFF year-on-year change?
Over the past year, ABCL quarterly cash flow from financing activities has changed by -$5.94M (-227.39%)
What is AbCellera Biologics Inc. TTM cash flow from financing activities?
The current TTM CFF of ABCL is $9.71M
What is the all time high TTM CFF for AbCellera Biologics Inc.?
AbCellera Biologics Inc. all-time high TTM cash flow from financing activities is $705.00M
What is AbCellera Biologics Inc. TTM CFF year-on-year change?
Over the past year, ABCL TTM cash flow from financing activities has changed by -$6.04M (-38.34%)